Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide extension study in early Parkinson's disease
NCT00642889Phase 3Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Jun 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of safinamide in Parkinson's disease (PD), sponsored by Newron Pharmaceuticals. Started Jun 2005; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00642889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642889.